Literature DB >> 2567440

Side-effects of ivermectin in treatment of onchocerciasis.

A Rothova1, A van der Lelij, J S Stilma, W R Wilson, R F Barbe.   

Abstract

In a prospective study to determine the tolerance for and safety of ivermectin therapy for onchocerciasis in a hyperendemic area in Sierra Leone, 28 (32%) of 87 patients had adverse reactions that required treatment with acetylsalicylic acid and antihistamines, but none of the observed adverse reactions were considered life-threatening. A significant relation was found between the frequency and severity of side-effects and the degree of parasite infestation, as quantified by the skin-snip counts. Free administration of ivermectin to severely infected onchocerciasis patients is not recommended without some form of medical supervision.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2567440     DOI: 10.1016/s0140-6736(89)90136-0

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

Review 1.  Anthelminthic agents: some recent developments and their clinical application.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-01       Impact factor: 2.401

2.  Decrease in adverse reactions after repeated ivermectin treatment in onchocerciasis.

Authors:  A Van der Lelij; A Rothova; N Klaassen-Broekema; W R Wilson; R F Barbe; J S Stilma
Journal:  Doc Ophthalmol       Date:  1990-10       Impact factor: 2.379

Review 3.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

Review 4.  Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis.

Authors:  K L Goa; D McTavish; S P Clissold
Journal:  Drugs       Date:  1991-10       Impact factor: 9.546

5.  Lethal LPS-independent side effects after microfilaricidal treatment in Acanthocheilonema viteae-infected rodents.

Authors:  H A Müller; H Zahner
Journal:  Parasitol Res       Date:  2005-07-05       Impact factor: 2.289

6.  Elevated serum angiotensin-converting enzyme activity in onchocerciasis.

Authors:  M J Ronday; A Van der Lelij; M Wienesen; A Rothova; J S Stilma; A Kijlstra
Journal:  Lung       Date:  1996       Impact factor: 2.584

7.  Effects of repeated ivermectin treatment in onchocerciasis.

Authors:  F L Njoo; J S Stilma; A van der Lelij
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

Review 8.  Points of action in the campaign against blindness in developing countries.

Authors:  J S Stilma; S Franken; M Hogeweg; P Hardus
Journal:  Doc Ophthalmol       Date:  1991       Impact factor: 2.379

9.  Suppression of human lymphocyte responses to specific and non-specific stimuli in human onchocerciasis.

Authors:  M Y Elkhalifa; H W Ghalib; T Dafa'Alla; J F Williams
Journal:  Clin Exp Immunol       Date:  1991-12       Impact factor: 4.330

Review 10.  Macrolides: From Toxins to Therapeutics.

Authors:  Kiersten D Lenz; Katja E Klosterman; Harshini Mukundan; Jessica Z Kubicek-Sutherland
Journal:  Toxins (Basel)       Date:  2021-05-12       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.